Results 61 to 70 of about 1,207 (150)

[Expression and significance of fibroblast growth factor receptor 2 in clear cell renal cell carcinoma]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban, 2022
Cai TY, Zhu ZP, Xu CR, Ji X, Lv TD, Guo ZK, Lin J.   +6 more
europepmc   +1 more source

透明细胞肾癌的表观扩散系数值与组织学分化程度的相关性分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2018
：【目的】分析透明细胞肾癌（CCRCC）的表观扩散系数（ADC）值与组织学分化程度的关系。【方法】 回顾性收集经病理证实的CCRCC患者63例，并根据Fuhrman病理分级Ⅰ～Ⅳ级标准，分为高分化组（Ⅰ级和Ⅱ 级）、中分化组（Ⅲ级）、低分化组（Ⅳ级），所有患者均行中腹部MR 平扫、增强和DWI 成像检查（1.5T，b = 800 s/ mm2)，分别测得CCRCC 的ADC 值，采用单因素方差比较不同CCRCC 组织学分化程度与ADC 值的差异，采用 ...
彭令荣, 刘卫敏, 江婷, 陈健宁, 孔庆聪   +4 more
doaj  

保留肾单位手术治疗早期肾癌29例临床分析

Zhongshan Daxue xuebao. Yixue kexue ban, 2008
【目的】 探讨保留肾单位的手术治疗早期肾癌的效果。【方法】 采用保留肾单位手术治疗肾癌29例,其中双侧肾癌3例,孤立肾肾癌2例, 单侧肾癌24例,其中对侧肾功能存在损害者14例,对侧肾功能正常者10例。【结果】 术后均未发生严重并发症,术后病理均为T1期,其中透明细胞癌21例, 乳头状肾癌5例, 囊性肾癌2例,嫌色细胞癌1例。术后平均随访49.8个月,肿瘤复发2例,复发率为6.9 %。1年、3年、5年无瘤生存率分别为100%、93.1%(27例)、82.8%(24例 ...
doaj  

[Therapeutic mechanism of natural astaxanthin against renal clear cell carcinoma based on network pharmacology and bioinformatics]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2021
Gao J, Yang D, Cao R, Pan X, Xia J.
europepmc   +1 more source

[MiR-744-5p inhibits the proliferation, invasion, and migration of clear-cell renal cell carcinoma cells by targeting CCND1]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao, 2022
Lei K, Xie W, Sun T, Liu Y, Wang X.
europepmc   +1 more source

核因子-κB相关信号在肾透明细胞癌中与预后和药物敏感性的关系 [PDF]

Ying Fu, Yu Xiang, Mengru Ceng, Long Qian, Zheng Dong   +4 more
openalex   +1 more source

Overexpression of CHMP2B suppresses proliferation of renal clear cell carcinoma cells. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen X, Wei Q, Zhang Z, Yuan J, Song W.
europepmc   +1 more source

[Quercetin inhibits proliferation and migration of clear cell renal cell carcinoma cells by regulating <i>TP53</i> gene]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Gao J, Ye K, Wu J.
europepmc   +1 more source

[Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus]. [PDF]

Beijing Da Xue Xue Bao Yi Xue Ban
Guo B, Lu M, Wang G, Zhang H, Liu L, Hou X, Zhao L, Tian X, Zhang S.   +8 more
europepmc   +1 more source

[Correlations of immune cell infiltration characteristics with clinicopathological parameters in patients with clear cell renal cell carcinoma]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Zhao H, Zhang G, Liu J, Mo F, Li T, Lei C, Lü S.   +6 more
europepmc   +1 more source